RHUMBLINE ADVISERS - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 99 filers reported holding ARATANA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$344,000
+53.6%
66,578
+6.9%
0.00%
Q1 2019$224,000
-40.7%
62,288
+1.1%
0.00%
-100.0%
Q4 2018$378,000
+56.8%
61,611
+49.2%
0.00%
Q3 2018$241,000
+33.9%
41,285
-2.5%
0.00%
Q2 2018$180,000
+13.2%
42,350
+17.3%
0.00%
Q1 2018$159,000
-18.9%
36,090
-3.0%
0.00%
Q4 2017$196,000
-34.4%
37,190
-23.6%
0.00%
-100.0%
Q3 2017$299,000
-14.3%
48,704
+1.0%
0.00%0.0%
Q2 2017$349,000
+59.4%
48,214
+16.4%
0.00%0.0%
Q1 2017$219,000
-11.3%
41,414
+20.4%
0.00%0.0%
Q4 2016$247,000
-23.3%
34,387
-0.2%
0.00%0.0%
Q3 2016$322,000
+53.3%
34,449
+3.8%
0.00%0.0%
Q2 2016$210,000
+19.3%
33,189
+4.1%
0.00%0.0%
Q1 2016$176,0000.0%31,874
+1.0%
0.00%0.0%
Q4 2015$176,000
-23.1%
31,564
+16.7%
0.00%0.0%
Q3 2015$229,000
-41.9%
27,049
+3.9%
0.00%0.0%
Q2 2015$394,000
-6.2%
26,035
-0.8%
0.00%0.0%
Q1 2015$420,000
+14.1%
26,240
+27.1%
0.00%0.0%
Q4 2014$368,000
+97.8%
20,640
+11.5%
0.00%0.0%
Q3 2014$186,000
-35.6%
18,5150.0%0.00%0.0%
Q2 2014$289,00018,5150.00%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
March Altus Capital Management LP 218,515$1,219,00011.21%
Broadfin Capital, LLC 3,428,865$19,133,0001.18%
MPM ASSET MANAGEMENT LLC 1,117,875$6,238,0001.11%
AlpInvest Partners B.V. 100,001$558,0000.93%
First Light Asset Management, LLC 395,043$2,204,0000.92%
Westend Capital Management, LLC 89,780$501,0000.69%
Grandeur Peak Global Advisors, LLC 460,675$2,571,0000.53%
AWM Investment Company, Inc. 467,507$2,609,0000.51%
HAMILTON LANE ADVISORS LLC 111,705$623,0000.27%
Sio Capital Management, LLC 97,376$543,0000.24%
View complete list of ARATANA THERAPEUTICS INC shareholders